189 related articles for article (PubMed ID: 17824787)
1. Population-based analysis of pathologic data: a new approach to the investigation of uterine endometrial and ovarian endometrioid carcinomas.
Henson DE; Schwartz AM; Tilara A; Grimley PM; Anderson WF
Arch Pathol Lab Med; 2007 Sep; 131(9):1337-42. PubMed ID: 17824787
[TBL] [Abstract][Full Text] [Related]
2. The impact of histological subtype in developing both ovarian and endometrial cancer: A longstanding nationwide incidence study.
van Niekerk CC; van Dijck JAAM; Verbeek ALM
Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():17-22. PubMed ID: 29227847
[TBL] [Abstract][Full Text] [Related]
3. The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.
Heckl M; Schmoeckel E; Hertlein L; Rottmann M; Jeschke U; Mayr D
PLoS One; 2018; 13(2):e0192881. PubMed ID: 29451900
[TBL] [Abstract][Full Text] [Related]
4. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
[TBL] [Abstract][Full Text] [Related]
5. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous presentation of carcinoma involving the ovary and the uterine corpus.
Eifel P; Hendrickson M; Ross J; Ballon S; Martinez A; Kempson R
Cancer; 1982 Jul; 50(1):163-70. PubMed ID: 7083121
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.
Li J; Zhu Q; Yang B; Ning C; Liu X; Luo X; Chen X
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():151-154. PubMed ID: 29408747
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of histologic homologues of endometrial and ovarian carcinoma.
Caduff RF; Svoboda-Newman SM; Bartos RE; Ferguson AW; Frank TS
Am J Surg Pathol; 1998 Mar; 22(3):319-26. PubMed ID: 9500773
[TBL] [Abstract][Full Text] [Related]
9. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
10. SPECIFICITIES OF ENDOMETRIAL PROLIFERATION/STEM CELL INDEX DISTRIBUTION IN ENDOMETRIOID CARCINOMA OF DIFFERENT GRADE OF MALIGNANCY.
Kikalishvili N; Beriashvili R; Muzashvili T; Burkadze G
Georgian Med News; 2018 Mar; (276):117-123. PubMed ID: 29697394
[TBL] [Abstract][Full Text] [Related]
11. Risk-based stratification of carcinomas concurrently involving the endometrium and ovary.
Turashvili G; Gómez-Hidalgo NR; Flynn J; Gonen M; Leitao MM; Soslow RA; Murali R
Gynecol Oncol; 2019 Jan; 152(1):38-45. PubMed ID: 30413340
[TBL] [Abstract][Full Text] [Related]
12. Simultaneously detected endometrial and ovarian carcinomas--a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study.
Zaino R; Whitney C; Brady MF; DeGeest K; Burger RA; Buller RE
Gynecol Oncol; 2001 Nov; 83(2):355-62. PubMed ID: 11606097
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis in endometrial cancer.
Caduff RF; Svoboda-Neumann SM; Johnston CM; Bartos RE; Frank TS
Verh Dtsch Ges Pathol; 1997; 81():219-27. PubMed ID: 9474873
[TBL] [Abstract][Full Text] [Related]
14. Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors.
Sturgeon SR; Sherman ME; Kurman RJ; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Brinton LA
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):231-5. PubMed ID: 9521439
[TBL] [Abstract][Full Text] [Related]
15. Synchronous endometrioid tumors of the ovary and endometrium. A clinicopathologic study of 22 cases.
Falkenberry SS; Steinhoff MM; Gordinier M; Rappoport S; Gajewski W; Granai CO
J Reprod Med; 1996 Oct; 41(10):713-8. PubMed ID: 8913971
[TBL] [Abstract][Full Text] [Related]
16. [Molecular carcinogenesis of ovarian carcinoma].
Diebold J
Verh Dtsch Ges Pathol; 2005; 89():77-83. PubMed ID: 18035676
[TBL] [Abstract][Full Text] [Related]
17. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases.
Zhang C; Sung CJ; Quddus MR; Simon RA; Jazaerly T; Lawrence WD
Hum Pathol; 2017 Jan; 59():120-124. PubMed ID: 27746268
[TBL] [Abstract][Full Text] [Related]
18. Histologic type, organ of origin, and Wnt pathway status: effect on gene expression in ovarian and uterine carcinomas.
Shedden KA; Kshirsagar MP; Schwartz DR; Wu R; Yu H; Misek DE; Hanash S; Katabuchi H; Ellenson LH; Fearon ER; Cho KR
Clin Cancer Res; 2005 Mar; 11(6):2123-31. PubMed ID: 15788657
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers.
Sozen H; Vatansever D; Iyibozkurt AC; Topuz S; Ozsurmeli M; Salihoglu Y; Guzelbey B; Berkman S
J Obstet Gynaecol Res; 2015 Nov; 41(11):1813-9. PubMed ID: 26369625
[TBL] [Abstract][Full Text] [Related]
20. Nationwide surveillance in uterine cancer: survival analysis and the importance of birth cohort: 30-year population-based registry in Taiwan.
Huang CY; Chen CA; Chen YL; Chiang CJ; Hsu TH; Lin MC; Lai MS; Chen CJ; You SL; Cheng WF
PLoS One; 2012; 7(12):e51372. PubMed ID: 23251510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
